SHZ · Financial Statements

Porton Pharma Solutions Ltd. (300363.SZ) Financial Statements

$21.65 SHZ: 300363.SZ Market Cap $12.39B

Full income statement, balance sheet, and cash flow statement for Porton Pharma Solutions Ltd. (300363.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA23.57
FCF Yield—
Quick Ratio1.28
Interest Coverage—
Return 1Y-11.97%
Return 3Y-16.86%
Return 5Y-76.18%

Porton Pharma Solutions Ltd. (300363.SZ) financials — frequently asked questions

What is 300363.SZ EV/EBITDA?

Porton Pharma Solutions Ltd.'s enterprise value to EBITDA (EV/EBITDA) ratio is 23.57.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
300363.SZ Overview 300363.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.